329 related articles for article (PubMed ID: 28526811)
1. Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.
Spreafico F; Bongarzone I; Pizzamiglio S; Magni R; Taverna E; De Bortoli M; Ciniselli CM; Barzanò E; Biassoni V; Luchini A; Liotta LA; Zhou W; Signore M; Verderio P; Massimino M
Oncotarget; 2017 Jul; 8(28):46177-46190. PubMed ID: 28526811
[TBL] [Abstract][Full Text] [Related]
2. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia.
Müller HL; Oh Y; Lehrnbecher T; Blum WF; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Aug; 79(2):428-34. PubMed ID: 7519190
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometry-based proteomics of cerebrospinal fluid in pediatric central nervous system malignancies: a systematic review with meta-analysis of individual patient data.
Mirian C; Thastrup M; Mathiasen R; Schmiegelow K; Olsen JV; Østergaard O
Fluids Barriers CNS; 2024 Feb; 21(1):14. PubMed ID: 38350915
[TBL] [Abstract][Full Text] [Related]
6. Cytomorphologic and clinicoradiologic analysis of primary nonhematologic central nervous system tumors with positive cerebrospinal fluid.
Ho CY; VandenBussche CJ; Huppman AR; Chaudhry R; Ali SZ
Cancer Cytopathol; 2015 Feb; 123(2):123-35. PubMed ID: 25487367
[TBL] [Abstract][Full Text] [Related]
7. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.
Macron C; Lane L; Núñez Galindo A; Dayon L
J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047
[TBL] [Abstract][Full Text] [Related]
8. Protein biomarker identification in the CSF of patients with CNS lymphoma.
Roy S; Josephson SA; Fridlyand J; Karch J; Kadoch C; Karrim J; Damon L; Treseler P; Kunwar S; Shuman MA; Jones T; Becker CH; Schulman H; Rubenstein JL
J Clin Oncol; 2008 Jan; 26(1):96-105. PubMed ID: 18056677
[TBL] [Abstract][Full Text] [Related]
9. Lipid-associated sialoprotein in the cerebrospinal fluid: association with brain malignancies.
Katopodis N; Glantz MJ; Kim L; Dafni U; Wu JK; Perides G
Cancer; 2001 Aug; 92(4):856-62. PubMed ID: 11550158
[TBL] [Abstract][Full Text] [Related]
10. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
[TBL] [Abstract][Full Text] [Related]
11. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
12. Pseudocholinesterase activity in cerebrospinal fluid as a biomarker of solid central nervous system tumors in children.
Mikecin L; Krizmaric M; Stepan Giljevic J; Gjurasin M; Kern J; Lenicek Krleza J; Popovic L
Croat Med J; 2013 Oct; 54(5):429-35. PubMed ID: 24170721
[TBL] [Abstract][Full Text] [Related]
13. A Chronic Fatigue Syndrome - related proteome in human cerebrospinal fluid.
Baraniuk JN; Casado B; Maibach H; Clauw DJ; Pannell LK; Hess S S
BMC Neurol; 2005 Dec; 5():22. PubMed ID: 16321154
[TBL] [Abstract][Full Text] [Related]
14. Concentrations of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3), IGF, and IGFBP-3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis.
Müller HL; Oh Y; Gargosky SE; Lehrnbecher T; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Nov; 77(5):1113-9. PubMed ID: 7521338
[TBL] [Abstract][Full Text] [Related]
15. Proteomic approach to profiling immune complex antigens in cerebrospinal fluid samples from patients with central nervous system autoimmune diseases.
Aibara N; Ichinose K; Baba M; Nakajima H; Satoh K; Atarashi R; Kishikawa N; Nishida N; Kawakami A; Kuroda N; Ohyama K
Clin Chim Acta; 2018 Sep; 484():26-31. PubMed ID: 29775619
[TBL] [Abstract][Full Text] [Related]
16. Neurodegeneration and humoral response proteins in cerebrospinal fluid associate with pediatric-onset multiple sclerosis and not monophasic demyelinating syndromes in childhood.
Bruijstens AL; Stingl C; Güzel C; Stoop MP; Wong YYM; van Pelt ED; Banwell BL; Bar-Or A; Luider TM; Neuteboom RF;
Mult Scler; 2023 Jan; 29(1):52-62. PubMed ID: 36154753
[TBL] [Abstract][Full Text] [Related]
17. Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors.
Ballester LY; Lu G; Zorofchian S; Vantaku V; Putluri V; Yan Y; Arevalo O; Zhu P; Riascos RF; Sreekumar A; Esquenazi Y; Putluri N; Zhu JJ
Acta Neuropathol Commun; 2018 Aug; 6(1):85. PubMed ID: 30170631
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid-based metabolomics to characterize different types of brain tumors.
Wang FX; Chen K; Huang FQ; Alolga RN; Ma J; Wu ZX; Fan Y; Ma G; Guan M
J Neurol; 2020 Apr; 267(4):984-993. PubMed ID: 31822990
[TBL] [Abstract][Full Text] [Related]
19. Robust two-dimensional separation of intact proteins for bottom-up tandem mass spectrometry of the human CSF proteome.
Bora A; Anderson C; Bachani M; Nath A; Cotter RJ
J Proteome Res; 2012 Jun; 11(6):3143-9. PubMed ID: 22537003
[TBL] [Abstract][Full Text] [Related]
20. Pediatric Ependymoma: A Proteomics Perspective.
Tsangaris GT; Papathanasiou C; Adamopoulos PG; Scorilas A; Vorgias CE; Prodromou N; Stathopoulou FT; Stravopodis DJ; Anagnostopoulos AK
Cancer Genomics Proteomics; 2017; 14(2):127-136. PubMed ID: 28387652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]